OrbiMed ^Investors

OrbiMed is a healthcare-dedicated investment firm with approximately $5 billion in assets under management. They invest globally in world-class healthcare companies to drive innovation, address unmet medical needs, and improve patient outcomes. Their investments span across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services. With a team of over 130 professionals, they manage approximately $17 billion across public and private company investments worldwide. Some of their notable investments include ADARx, a company developing a proprietary RNA targeting platform, and SpringWorks, which applies a precision medicine approach to acquiring, developing, and commercializing healthcare solutions.